“ Therapeutic Monoclonal Antibodies: ScFv Patents As a Marker of a New Class of Potential Biopharmaceuticals ”. Brazilian Journal of Pharmaceutical Sciences 47, no. 1 (March 1, 2011): 31–38. Accessed July 17, 2024. https://revistas.usp.br/bjps/article/view/10853.